Biofrontera annual operating margin
2020
2021
2022
2023
2024
2025
Biofrontera's operating margin was −27.21% for fiscal 2025.
View full Biofrontera company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −27.21% | +18.90 pp |
| 2024 | 2024-12-31 | −46.11% | +20.44 pp |
| 2023 | 2023-12-31 | −66.56% | −1.76 pp |
| 2022 | 2022-12-31 | −64.80% | +39.77 pp |
| 2021 | 2021-12-31 | −104.57% | −53.61 pp |
| 2020 | 2020-12-31 | −50.96% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −4.37% | +51.88 pp |
| Q1 2026 | 2026-03-31 | −42.84% | +10.11 pp |
| Q4 2025 | 2025-12-31 | 26.64% | +40.28 pp |
| Q3 2025 | 2025-09-30 | −89.84% | −34.80 pp |
| Q2 2025 | 2025-06-30 | −56.25% | +8.44 pp |
| Q1 2025 | 2025-03-31 | −52.95% | +16.15 pp |
| Q4 2024 | 2024-12-31 | −13.63% | +22.86 pp |
| Q3 2024 | 2024-09-30 | −55.04% | −3.10 pp |
| Q2 2024 | 2024-06-30 | −64.69% | +84.06 pp |
| Q1 2024 | 2024-03-31 | −69.10% | −6.21 pp |
| Q4 2023 | 2023-12-31 | −36.49% | +18.91 pp |
| Q3 2023 | 2023-09-30 | −51.93% | +32.26 pp |
| Q2 2023 | 2023-06-30 | −148.75% | −9.38 pp |
| Q1 2023 | 2023-03-31 | −62.89% | −30.99 pp |
| Q4 2022 | 2022-12-31 | −55.40% | −34.88 pp |
| Q3 2022 | 2022-09-30 | −84.20% | +287.40 pp |
| Q2 2022 | 2022-06-30 | −139.38% | −76.40 pp |
| Q1 2022 | 2022-03-31 | −31.89% | +42.47 pp |
| Q4 2021 | 2021-12-31 | −20.52% | +51.56 pp |
| Q3 2021 | 2021-09-30 | −371.60% | — |
| Q2 2021 | 2021-06-30 | −62.97% | — |
| Q1 2021 | 2021-03-31 | −74.37% | — |
| Q3 2020 | 2020-09-30 | −72.08% | — |
Over the last five reported fiscal years, Biofrontera's operating margin increased from −50.96% to −27.21%, a change of +23.75 percentage points. The latest reported quarter, Q2 2026, shows −4.37%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biofrontera filings at SEC.gov ↗